PHAXIAM Therapeutics S.A. (PHXM) — Cash Flow Quality Index

Latest as of December 2022: -1.87x

PHAXIAM Therapeutics S.A. (PHXM) has a Cash Flow Quality Index of -1.87x as of December 2022. Operating cash flow of €-11.10 Million is below net income of €5.93 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PHAXIAM Therapeutics S.A. long-term investment allocation to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.87x

Operating CF / Net Income

Operating Cash Flow

€-11.10 Million

EUR

Net Income

€5.93 Million

EUR

Data as of

Dec 2022

Most recent filing

Annual Cash Flow Quality Index for PHAXIAM Therapeutics S.A. (None–None)

Year-by-year earnings quality comparison for PHAXIAM Therapeutics S.A.. For live market cap and the full company financial profile, see PHAXIAM Therapeutics S.A. (PHXM) total market value.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.